dc.contributor.author |
Gunasekera, S. |
|
dc.contributor.author |
Fernando*, S. |
|
dc.date.accessioned |
2022-06-25T10:01:41Z |
|
dc.date.available |
2022-06-25T10:01:41Z |
|
dc.date.issued |
2022-06 |
|
dc.identifier.uri |
http://ichemcdr.com:8080/xmlui/handle/123456789/175 |
|
dc.description |
Abstract:No.42 |
en_US |
dc.description.abstract |
New topical cream formulations for dermatological
treatment against broad spectrum antimycotic agent
and various inflammatory conditions contain a
combination of Clotrimazole (CT) and Beclomethasone
Dipropionate (BD). |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Institute of Chemistry Ceylon |
en_US |
dc.relation.ispartofseries |
39;1 |
|
dc.subject |
Clotrimazole |
en_US |
dc.subject |
Beclomethasone Dipropionate |
en_US |
dc.subject |
Tri-ethylamine |
en_US |
dc.subject |
correlation coefficient |
en_US |
dc.subject |
antimycotic |
en_US |
dc.title |
Development and validation of new method for the simultaneous determination of Clotrimazole and Beclomethasone Dipropionate by HPLC in topical cream formulation |
en_US |
dc.type |
Article |
en_US |